Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × AZD9833 × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neoplasms by Site 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Skin Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Endometrial Neoplasms 1 ER+ HER2- Advanced Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 4 Letrozole 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 palbociclib 2 talazoparib 1 pyrotinib 1 olaparib 1 eribulin 1 elacestrant 1 disitamab vedotin 1 dalpiciclib 1 abemaciclib 1 Vinorelbine 1 Sirolimus 1 Safety 1 Ritonavir 1 Itraconazole 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07427394 2026-02-23

SERENA-1b

AstraZeneca

Phase 2 Not yet recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡